Document:

EXHIBIT 10.1

Execution Version

 

 

SERIES B PREFERRED STOCK PURCHASE AGREEMENT

 

THIS SERIES B PREFERRED
STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of the 15th day of March, 2013, by and between Frederick’s
of Hollywood Group Inc., a New York corporation (the “Company”), and Five Island Asset Management LLC, a Delaware
limited liability company (the “Purchaser”).

 

The parties hereby
agree as follows:

 

1.                 
Purchase and Sale of Preferred Stock.

 

1.1             
Sale and Issuance of Series B Preferred Stock; Closing; Disclosure.

 

(a)               
The Company shall adopt the Certificate of Amendment in the form of Exhibit A attached to this Agreement (the
“Certificate of Amendment”) and, after the close of trading of the Company’s common stock, $0.01 par value
per share (the “Common Stock”) on the date hereof, file the Certificate of Amendment with the Secretary of State
of the State of New York.

 

(b)              
Subject to the terms and conditions of this Agreement, the Purchaser agrees to purchase and the Company agrees to sell and
issue to the Purchaser 100,000 shares of Series B Convertible Preferred Stock, $0.01 par value per share, of the Company (the
“Series B Preferred Stock”), at a purchase price of $100.00 per share. The shares of Series B Preferred Stock
issued to the Purchaser pursuant to this Agreement shall be referred to in this Agreement as the “Shares.”

 

(c)               
The closing of the purchase and sale of the Shares provided for hereunder (the “Closing”) shall occur
remotely via the exchange of documents and signatures on the date hereof but after the close of trading of the Company’s
Common Stock and after the filing of the Certificate of Amendment as provided in subsection (b) above. Except as required
by applicable Law, the Company shall not, prior to the Closing, disclose to any third parties other than its advisors the existence
of, or any information concerning, this Agreement or the transactions contemplated by this Agreement. Prior to making any public
disclosure of this Agreement or the transactions contemplated by this Agreement, the Company shall provide the Purchaser and its
counsel with a draft of the disclosure and provide them with the opportunity to provide the Company with comments on the disclosure.

 

1.2             
Defined Terms Used in this Agreement. In addition to the terms defined
above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.

 

(a)               
“Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly,
controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing
member, officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more
general partners or managing members of, or shares the same management company with, such Person.

 

    	 

    	 

    

  

(b)              
“Board” means the board of directors of the Company.

 

(c)               
“By-laws” means the By-laws of the Company, as may be amended in accordance with the terms of this Agreement,
the Certificate of Amendment and applicable Law from time to time.

 

(d)              
“Code” means the Internal Revenue Code of 1986, as amended.

 

(e)               
“Commission” means the United States Securities and Exchange Commission.

 

(f)               
“Company Intellectual Property” means all patents, patent applications, trademarks, trademark applications,
service marks, service mark applications, tradenames, copyrights, trade secrets, domain names, mask works, information and proprietary
rights and processes, similar or other intellectual property rights, subject matter of any of the foregoing, tangible embodiments
of any of the foregoing, licenses in to and under any of the foregoing, and any and all such cases that are owned or used by the
Company in the conduct of the Company’s business as now conducted and as presently proposed to be conducted.

 

(g)              
“Control” means the possession, directly or indirectly, of the power to direct or cause the direction
of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. “Controlling”
and “Controlled” have meanings correlative thereto.

 

(h)              
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time.

 

(i)                
“ERISA Affiliate” means any trade or business (whether or not incorporated) that, together with the Company,
is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of
ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.

 

(j)                
“ERISA Event” means (a) any “reportable event”, as defined in Section 4043 of ERISA
or the regulations issued thereunder with respect to a Plan (other than an event for which the 30 day notice period is
waived), (b) the existence with respect to any Plan of an “accumulated funding deficiency” (as defined in Section 412
of the Code or Section 302 of ERISA), whether or not waived, (c) the filing pursuant to Section 412(d) of the Code
or Section 303(d) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan, (d) the
incurrence by the Company or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination
of any Plan, (e) the receipt by the Company or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating
to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (f) the incurrence by the Company
or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal from any Plan or Multiemployer
Plan, or (g) the receipt by the Company or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from
the Company or any ERISA Affiliate of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer
Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of ERISA.

 

    	2

    	 

    

  

(k)              
“GAAP” means generally accepted accounting principles in the United States of America.

 

(l)                
“Governmental Authority” means the government of the United States of America, any other nation or any
political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central
bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or
pertaining to government.

 

(m)            
“Law” means any and all laws, statutes, rules, regulations, ordinances and other pronouncements having
the effect of law of the United States, any foreign country or any domestic or foreign state, county, city or other political subdivision
or of any Governmental Authority.

 

(n)              
“Material Adverse Effect” means a material adverse effect on the business, assets (including intangible
assets), liabilities, financial condition, property or results of operations of the Company.

 

(o)              
“Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA.

 

(p)              
“Option” with respect to any Person means any security, right, subscription, warrant, option, “phantom”
stock right or other contract that gives the right to (i) purchase or otherwise receive or be issued any shares of capital stock
of such Person or any security of any kind convertible into or exchangeable or exercisable for any shares of capital stock of such
Person or (ii) receive or exercise any benefits or rights similar to any rights enjoyed by or accruing to the holder of shares
of capital stock of such Person, including any rights to participate in the equity or income of such Person or to participate in
or direct the election of any directors or officers of such Person or the manner in which any shares of capital stock of such Person
are voted.

 

(q)              
“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor
entity performing similar functions.

 

(r)                
“Person” means any individual, corporation, partnership, trust, limited liability company, association
or other entity.

 

(s)               
“Plan” means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions
of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, and in respect of which the Company or
any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an “employer”
as defined in Section 3(5) of ERISA.

 

(t)                
“Registrable Securities” means shares of Common Stock underlying the Shares and the shares of Common
Stock underlying any shares of Series B Preferred Stock issued as dividends on the Shares, and the shares of Common Stock underlying
the Warrants. As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when: (a) a
Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such
securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (b) such
securities shall have been otherwise transferred, new certificates for them not bearing a legend restricting further transfer shall
have been delivered by the Company and subsequent public distribution of them shall not require registration under the Securities
Act; (c) such securities shall have ceased to be outstanding, or (d) the Registrable Securities are freely saleable under Rule
144 without volume limitations.

 

    	3

    	 

    

  

(u)              
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated
thereunder.

 

(v)              
“subsidiary” means with respect to any Person (the “parent”) at any date, any corporation,
limited liability company, partnership, association or other entity the accounts of which would be consolidated with those of the
parent in the parent’s consolidated financial statements if such financial statements were prepared in accordance with GAAP
as of such date, as well as any other corporation, limited liability company, partnership, association or other entity (a) of
which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary
voting power or, in the case of a partnership, more than 50% of the general partnership interests are, as of such date, owned,
controlled or held, or (b) that is, as of such date, otherwise Controlled, by the parent or one or more subsidiaries of the
parent or by the parent and one or more subsidiaries of the parent.

 

(w)            
“Subsidiary” means any subsidiary of the Company.

 

(x)              
“Tax” means any present or future tax, levy, impost, duty, deduction, withholding, assessment, fee or
other charge imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.

 

2.                 
Representations and Warranties of the Company. The Company hereby
represents and warrants to the Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit B to this
Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations
are true and complete as of the date hereof. The Disclosure Schedule shall be arranged in sections corresponding to the numbered
and lettered sections and subsections contained in this Section 2, and the disclosures in any section or subsection of the
Disclosure Schedule shall qualify other sections and subsections in this Section 2 only to the extent it is readily apparent
from a reading of the disclosure that such disclosure is intended to be applicable to such other sections and subsections.

 

For purposes of these
representations and warranties (other than those in Subsections 2.2, 2.3, 2.4, 2.5, and 2.6),
the term “the Company” shall include any subsidiaries of the Company, unless otherwise noted herein.

 

2.1             
Organization, Good Standing, Corporate Power and Qualification

 

. The Company is a
corporation duly organized, validly existing and in good standing under the laws of the State of New York and has all requisite
corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. The Company is duly
qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material
Adverse Effect.

 

    	4

    	 

    

  

2.2             
Capitalization.

 

(a)               
The authorized capital of the Company consists, as of the date hereof, of:

 

(i)                
200,000,000 shares of Common Stock, 39,070,366 shares of which are issued and outstanding. All of the outstanding shares
of Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal
and state securities laws.

 

(ii)              
10,000,000 shares of Preferred Stock, of which 125,000 shares have been designated as Series A Convertible Preferred
Stock (“Series A Preferred Stock” and together with the Series B Preferred Stock, the “Preferred Stock”)
and of which 300,000 shares have been designated as Series B Preferred Stock. The rights, privileges and preferences of the Preferred
Stock are as stated in the Certificate of Incorporation of the Company, as amended (including, for the avoidance of doubt, the
amendments provided in the Certificate of Amendment), and as provided by the New York Business Corporation Law. There are 53,178
outstanding shares of Series A Preferred Stock and, except for such shares, no other shares of Series A Preferred Stock are outstanding.

 

(b)              
Except as set forth in Subsection 2.2(a) hereof and Section 2.2(b) of the Disclosure Schedule, there are no
other shares of capital stock of the Company or Options issued or outstanding. The Company has reserved a sufficient number of
shares of Common Stock to be issued in connection with the Preferred Stock and the Options.

 

2.3             
Subsidiaries. Except as set forth in Section 2.3 of the Disclosure
Schedule, the Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership,
trust, joint venture, limited liability company, association, or other business entity. The Company owns all of the stock in its
subsidiaries. The Company is not a participant in any joint venture, partnership or similar arrangement.

 

2.4             
Authorization. All corporate action required to be taken by the Company
in order to authorize the Company to enter into this Agreement, issue the Warrants (as hereinafter defined), file the Certificate
of Amendment and issue the Shares and Warrants and the Common Stock issuable upon conversion of the Shares or exercise of the Warrants,
has been taken. All action on the part of the officers of the Company necessary for the execution and delivery of this Agreement
and the other documents referenced above, the performance of all obligations of the Company under this Agreement to be performed,
and the issuance and delivery of the Shares has been taken. The Agreement, the Warrants and the Certificate of Amendment, when
executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against
the Company in accordance with their respective terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other
equitable remedies, or (iii) to the extent indemnification provisions may be limited by applicable federal or state securities
laws.

 

    	5

    	 

    

  

2.5             
Valid Issuance of Shares. The Shares and Warrants, when issued, sold
and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully
paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under applicable state and federal
securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations
of the Purchaser in Section 3 of this Agreement and subject to the filings described in Subsection 2.6 below, the Shares
will be issued, in compliance with all applicable federal and state securities laws. The shares of Series B Preferred Stock that
will be issued as dividends on the Shares and on other shares of Series B Preferred Stock that will have been issued as dividends,
when issued and delivered in accordance with the terms of the Certificate of Amendment, will be validly issued, fully paid and
nonassessable and free of restrictions on transfer other than restrictions on transfer under applicable state and federal securities
laws and liens or encumbrances created by or imposed by the Purchaser. The Common Stock issuable upon conversion of the Shares
and exercise of the Warrants has been duly reserved for issuance, and upon issuance in accordance with the terms of the Certificate
of Amendment or the Warrants, as the case may be, will be validly issued, fully paid and nonassessable and free of restrictions
on transfer other than restrictions on transfer under applicable federal and state securities laws and liens or encumbrances created
by or imposed by the Purchaser. Based in part upon the representations of the Purchaser in Section 3 of this Agreement, and
subject to Subsection 2.6 below, the Common Stock issuable upon conversion of the Shares and exercise of the Warrants will
be issued in compliance with all applicable federal and state securities laws.

 

2.6             
Consents and Filings. Assuming the accuracy of the representations
made by the Purchaser in Section 3 of this Agreement, no consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any Governmental Authority or any other Person is required on the part of the Company
in connection with the consummation of the transactions contemplated by this Agreement, except for (i) the filing of the Certificate
of Amendment, which will have been filed as of the date hereof, (ii) the filing with the Commission of a Current Report on Form
8-K with respect to the transactions contemplated hereby, (iii) the written consent of the holders of at least a majority of the
outstanding Series A Preferred Stock and (iv) filings pursuant to Regulation D of the Securities Act, and applicable
state securities laws, which have been made or will be made in a timely manner.

 

2.7             
Compliance with Other Instruments. Except as set forth on Section
2.7 of the Disclosure Schedule, the Company is not in violation or default (i) of any provisions of its Restated Certificate
of Incorporation or By-laws, (ii) of any instrument, judgment, order, writ or decree, (iii) under any credit agreement or facility,
note, indenture or mortgage, (iv) under any lease, agreement, contract or purchase order to which it is a party or by which it
is bound, or (v) of any provision of Law, except in the case of each of clauses (iv) and (v), such as would not reasonably be expected
to result in a Material Adverse Effect, and the execution, delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby will not result in any violation or default of or under, or any conflict with (in each case, with
or without the passage of time and giving of notice) any of the provisions, instruments, judgments, orders, writs, decrees, agreements,
notes, indentures, mortgages, leases, agreements, contracts, purchase orders, or Laws set forth in clauses (i) through (v) of this
Subsection 2.7. Without limiting the generality of the foregoing, the delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby will not result in any event which results in the creation of any lien, charge or encumbrance
upon any assets of the Company or any of its subsidiaries or the suspension, revocation, forfeiture, or nonrenewal of any material
permit or license applicable to the Company.

 

    	6

    	 

    

  

2.8             
Rights of Registration. The Company is not under any obligation to
register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion
of its currently outstanding securities.

 

2.9             
Property. Except as set forth in Section 2.9 of the Disclosure
Schedule, the property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances,
except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in
the ordinary course of business and do not materially impair the Company’s ownership or use of such property or assets. With
respect to the property and assets it leases, the Company is in compliance with such leases and, to its knowledge, holds a valid
leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company
does not own any real property.

 

2.10         
SEC Filings; Financial Statements. The Company has delivered or made
available to the Purchaser prior to the execution of this Agreement, true and complete copies of all periodic reports, registration
statements and proxy statements filed by it with the Commission since July 27, 2008. Each of such filings with the Commission (collectively,
the “SEC Filings”), as of its filing date, complied in all material respects with the requirements of the rules
and regulations promulgated by the Commission with respect thereto and did not contain any untrue statement of a material fact
or omit a material fact necessary in order to make the statements contained therein not misleading in light of the circumstances
in which such statements were made. The financial statements included in the SEC Filings (the “Financial Statements”)
have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated, except that the unaudited
Financial Statements may not contain all footnotes required by GAAP. The Financial Statements fairly present in all material respects
the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in
the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements,
the Company has no material liabilities or obligations, contingent or otherwise, other than (i) as described in the draft of the
Quarterly Report on Form 10-Q for the quarter ended January 26, 2013 previously furnished to the Purchaser by the Company on March
7, 2013 (“Draft 10-Q”), (ii) liabilities incurred in the ordinary course of business subsequent to October 27,
2012, (iii) obligations under contracts and commitments incurred in the ordinary course of business and (iv) liabilities
and obligations of a type or nature not required under GAAP to be reflected in the Financial Statements, which, in all such cases,
individually and in the aggregate, would not have a Material Adverse Effect. The Company maintains and will continue to maintain
a standard system of accounting established and administered in accordance with GAAP.

 

    	7

    	 

    

  

2.11         
Changes. Except as described in the Draft 10-Q, since October 27,
2012, the Company and its subsidiaries, taken as a whole, has not suffered any Material Adverse Effect, except for those occurring
as a result of general economic or financial conditions affecting the United States as a whole or the region in which the Company
conducts its business or developments that are not unique to the Company but also affect other entities engaged or participating
in the women’s intimate apparel industry generally in a manner not materially less severely. 

 

2.12         
Insurance. The Company has in full force and effect fire and casualty
insurance policies with extended coverage, sufficient in amount (subject to reasonable deductions) to allow it to replace any of
its properties that might be damaged or destroyed.

 

2.13         
Permits. The Company has all franchises, permits, licenses and any
similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material
Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other
similar authority.

 

2.14         
Compliance with Laws. Since October 27, 2012, the Company has conducted
its business in compliance with all applicable Laws, court or administrative orders and processes and rules, directives and orders
of regulatory and self-regulatory agencies and bodies, except as would not reasonably be expected, individually or in the aggregate,
to have a Material Adverse Effect.

 

2.15         
Labor Relations. Neither the Company nor any of its Subsidiaries
is engaged in any unfair labor practice that could reasonably be expected to have a Material Adverse Effect. There is (a) no
significant unfair labor practice complaint pending against the Company or any of its Subsidiaries or, to the best knowledge of
the Company, threatened in writing against any of them before the National Labor Relations Board or any similar governmental authority
in any jurisdiction, and no significant grievance or significant arbitration proceeding arising out of or under any collective
bargaining agreement is so pending against the Company or any of its Subsidiaries or, to the best knowledge of the Company, threatened
in writing against any of them, (b) no significant strike, labor dispute, slowdown or stoppage is pending against the Company
or any of its Subsidiaries or, to the best knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries
and (c) to the best knowledge of the Company, no question concerning union representation exists with respect to the employees
of the Company or any of its Subsidiaries, except (with respect to any matter specified in clause (a), (b) or (c) above,
either individually or in the aggregate) such as could not reasonably be expected to have a Material Adverse Effect.

 

2.16         
Intellectual Property. Each of the Company and its Subsidiaries owns,
or is licensed to use, all trademarks, tradenames, copyrights, patents and other intellectual property material to its business,
and the use thereof by the Company and its Subsidiaries does not infringe upon the rights of any other person or entity, except
for any such infringements that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse
Effect.

 

    	8

    	 

    

  

2.17         
Litigation. Except as set forth in Section 2.17 of the Disclosure
Schedule, there are no actions, suits or proceedings by or before any arbitrator or Governmental Authority pending against the
Company or any of its Subsidiaries or, to the knowledge of the Company, threatened against or affecting the Company or any of its
Subsidiaries, that would result in a judgment or judgments against the Company or any of its Subsidiaries in an amount in excess
of $200,000 or that could reasonably be expected to have a Material Adverse Effect or, to the knowledge of the Company, that involve
this Agreement or the transactions contemplated hereby.

 

2.18         
Taxes. Each of the Company and its Subsidiaries has timely filed
or caused to be filed all Tax returns and reports required to have been filed and has paid or caused to be paid all Taxes required
to have been paid by it, except (a) Taxes that are being contested in good faith by appropriate proceedings and for which
the Company or such Subsidiary, as applicable, has set aside on its books adequate reserves or (b) to the extent that the
failure to do so could not reasonably be expected to result in a Material Adverse Effect.

 

2.19         
ERISA. No ERISA Event has occurred or is reasonably expected to occur
that, when taken together with all other such ERISA Events for which liability is reasonably expected to occur, could reasonably
be expected to result in a Material Adverse Effect. The present value of all accumulated benefit obligations under each Plan (based
on the assumptions used for purposes of Statement of Financial Accounting Standards No. 87) did not, as of the date of the most
recent financial statements reflecting such amounts, exceed the fair market value of the assets of such Plan, and the present value
of all accumulated benefit obligations of all underfunded Plans (based on the assumptions used for purposes of Statement of Financial
Accounting Standards No. 87) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the
fair market value of the assets of all such underfunded Plans.

 

2.20         
Solvency. Immediately after the consummation of the transactions
contemplated by this Agreement (i) the fair value of the assets of each of the Company and Subsidiaries at a fair valuation,
will exceed its debts and liabilities, subordinated, contingent or otherwise; (ii) the present fair saleable value of the
property of each of the Company and its Subsidiaries will be greater than the amount that will be required to pay the probable
liability of its debts and other liabilities, subordinated, contingent or otherwise, as such debts and other liabilities become
absolute and matured; (iii) each of the Company and its Subsidiaries will be able to pay its debts and liabilities, subordinated,
contingent or otherwise, as such debts and liabilities become absolute and matured; and (iv) each of the Company and its Subsidiaries
will not have unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted
and is proposed to be conducted after the date hereof.

 

2.21         
Disclosure. The Company has disclosed to the Purchaser all agreements,
instruments and corporate or other restrictions to which it or any of its Subsidiaries is subject, and all other matters known
to it, that, individually or in the aggregate, could reasonably be expected to result in a Material Adverse Effect. None of the
reports, financial statements, certificates or other information furnished by or on behalf of the Company or any of its Subsidiaries
to the Purchaser in connection with the negotiation of this Agreement or delivered hereunder (as modified or supplemented by other
information so furnished) contains any material misstatement of fact or omits to state any material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that, with respect to
projected financial information, the Company represents only that such information was prepared in good faith based upon assumptions
believed to be reasonable at the time.

 

    	9

    	 

    

  

3.                 
Representations and Warranties of the Purchaser. The Purchaser hereby
represents and warrants to the Company that:

 

3.1             
Authorization. The Purchaser has full power and authority to enter
into this Agreement. The Agreement, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations
of the Purchaser, enforceable in accordance with their terms, except (a) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors’
rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies, or (b) to the extent indemnification provisions may be limited by applicable federal or state securities laws.

 

3.2             
Purchase Entirely for Own Account. This Agreement is made with the
Purchaser in reliance upon the Purchaser’s representation to the Company, which by the Purchaser’s execution of this
Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the
Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof,
and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same in
violation of the securities laws of the United States. By executing this Agreement, the Purchaser further represents that the Purchaser
does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations
to such Person or to any third Person, with respect to any of the Shares. The Purchaser has not been formed for the specific purpose
of acquiring the Shares.

 

3.3             
Disclosure of Information. The Purchaser has had an opportunity to
discuss the Company’s business, management, financial affairs and the terms and conditions of the offering of the Shares
with the Company’s management and has had an opportunity to review the Company’s facilities, SEC Filings and Draft
10-Q. The foregoing, however, does not limit or modify the representations and warranties of the Company in Section 2 of this
Agreement or the right of the Purchaser to rely thereon.

 

3.4             
Restricted Securities. The Purchaser understands that the Shares
have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions
of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of
the Purchaser’s representations as expressed herein. The Purchaser understands that the Shares are “restricted securities”
under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares
indefinitely unless they are registered with the Commission and qualified by state authorities, or an exemption from such registration
and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify
the Shares or Warrants, or the Common Stock into which it may be converted or exercised, as applicable, for resale except as set
forth in this Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available,
it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for
the Shares, and on requirements relating to the Company which are outside of the Purchaser’s control, and which the Company
is under no obligation and may not be able to satisfy.

 

    	10

    	 

    

  

3.5             
No Public Market. The Purchaser understands that no public market
now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.

 

3.6             
Legends. The Purchaser understands that the Shares and any securities
issued in respect of or exchange for the Shares, will bear the following legend:

 

“THE SHARES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY
NOT BE SOLD OR TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM UNDER THE SECURITIES ACT OR STATE
SECURITIES LAWS.”

 

3.7             
Accredited Investor. The Purchaser is an accredited investor as defined
in Rule 501(a) of Regulation D promulgated under the Securities Act.

 

3.8             
Foreign Investors. If the Purchaser is not a United States person
(as defined by Section 7701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full
observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement,
including (i) the legal requirements within its jurisdiction for the purchase of the Shares, (ii) any foreign exchange
restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the
income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of
the Shares. The Purchaser’s subscription and payment for and continued beneficial ownership of the Shares will not violate
any applicable securities or other laws of the Purchaser’s jurisdiction.

 

3.9             
No General Solicitation. Neither the Purchaser, nor any of its officers,
directors, employees, agents, stockholders or partners has either directly or indirectly, including through a broker or finder
(a) engaged in any general solicitation, or (b) published any advertisement in connection with the offer and sale of
the Shares.

 

3.10         
Exculpation Among Purchasers. The Purchaser acknowledges that it
is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to
invest in the Company.

 

3.11         
Residence. The principal place of business of the Purchaser is identified
in the address of the Purchaser set forth on the signature page hereof.

 

    	11

    	 

    

  

4.                 
Deliveries by the Company. On or before the date hereof, the Company
shall deliver the following to Purchaser:

 

4.1             
Company Compliance Certificate. The Chief Executive Officer of the
Company shall deliver to the Purchaser a certificate certifying that (i) the representations and warranties of the Company
contained in Section 2 that are (A) qualified as to materiality are true and correct and (B) not qualified as to
materiality are true and correct in all material respects and (ii) the Company shall have performed and complied with all
covenants, agreements, obligations and conditions in this Agreement that are required to be performed or complied with by the Company
on or before the date hereof.

 

4.2                                                             
Opinion of Company Counsel. The Purchaser shall have received from
Graubard Miller, counsel for the Company, an opinion in substantially the form of Exhibit C attached to this Agreement.

 

4.3             
Amendments to Certain Corporate Documents.

 

(a)               
The Company shall have filed the Certificate of Amendment with the Secretary of State of New York.

 

(b)              
The Company shall have duly adopted the amendments to its By-laws as set forth on Exhibit D.

 

4.4             
Secretary’s Certificate. The Secretary of the Company shall
have delivered to the Purchaser a certificate certifying (i) the Restated Certificate of Incorporation and By-laws of the
Company and (ii) resolutions of the Board approving the Agreement, the transactions contemplated under the Agreement and the
Certificate of Amendment (including, without limitation, a waiver of Section 912(b) of the New York Business Corporation Law).

 

4.5             
Expenses. The Company shall pay, or reimburse the Purchaser for,
all reasonable expenses incurred (including but not limited to reasonable attorneys’ fees and disbursements) in an amount
not to exceed $ 200,000 in connection with the negotiation and documentation of this Agreement and the ancillary documents hereto
and the issuance of the Shares to it hereunder and thereafter.

 

4.6             
Shares. The Company shall deliver to the Purchaser a certificate
representing the Shares.

 

4.7             
Warrants. The Company shall have duly executed and issued to the
Purchaser each of the warrants attached hereto as Exhibits E-1 through E-6 (the “Warrants”).

 

5.                 
Deliveries by the Purchaser.

 

5.1             
Purchase Price. The Purchaser shall pay the purchase price for the
Shares by wire transfer to a bank account designated by the Company.

 

5.2             
Purchaser Compliance Certificate. The Purchaser shall deliver to
the Company a certificate certifying that (i) the representations and warranties of the Purchaser contained in Section 3
that are (A) qualified as to materiality are true and correct and (B) not qualified as to materiality are true and correct
in all material respects and (ii) the Purchaser shall have performed and complied with all covenants, agreements, obligations
and conditions in this Agreement that are required to be performed or complied with by the Purchaser on or before the date hereof.

 

    	12

    	 

    

  

6.                 
Additional Obligations.

 

6.1             
Registration Rights. Within 60 days after the Closing,
the Company shall (i) file a registration statement (“Registration Statement”) with the Commission
covering the resale by the Purchaser of the Registrable Securities, (ii) use its best efforts to have such Registration Statement
declared effective as promptly as practicable thereafter, and (iii) keep the Registration Statement effective until (1) the
date on which the Registrable Securities may be resold by the Purchaser without registration under the Securities Act and without
regard to any volume limitations by reason of Rule 144 under the Securities Act or any other rule of similar effect or (2) all
of the Registrable Securities have been sold pursuant to the Registration Statement or Rule 144 under the Securities Act or
any other rule of similar effect. The Purchaser understands, however, that notwithstanding this obligation on the part of the Company
to register the resale of the Registrable Securities and to keep the Registration Statement effective, there is no assurance that
the Company will be able to have the Registration Statement declared effective and keep the Registration Statement effective until
the Purchaser has sold all the Registrable Securities owned by the Purchaser registered thereon. The Company’s obligation
to register the Registrable Securities pursuant to the Registration Statement shall be subject to the Purchaser’s delivery
to the Company of such information regarding the Purchaser, the securities of the Company held by the Purchaser, and the intended
method of disposition of the Registrable Securities as reasonably required by the Company to effect the registration of such Registrable
Securities. The Company shall, promptly upon receipt of notice of a transfer by the Purchaser, add to the Registration Statement
any transferee of the Shares, any transferee of any shares of Series B Preferred Stock issued as dividends on the Shares, and any
transferee of the Warrants. In addition to, and without limiting the generality of, the foregoing, Purchaser shall have the additional
registration rights set forth on Exhibit F.

 

6.2             
Use of Proceeds. The Company shall use the proceeds of the sale of
Shares hereunder solely for ordinary course working capital and operational requirements of the Company and for paying, settling
or discharging accounts payable of the Company.

 

6.3             
Actions Required With Respect to Dividends. The Company shall take
all actions required or permitted under the Business Corporation Law of the State of New York (the “BCL”) (a) to
permit the payment of the Series B Preferred Dividend (as defined in the Certificate of Amendment), including through the revaluation
of its assets in accordance with the BCL, to make or keep funds legally available for the payment of dividends and (b) to
declare and pay such dividends.

 

6.4             
Stockholder Meeting; Proxy Material.

 

(a)               
The Company shall cause a general or special meeting of its shareholders (the “Company Shareholders' Meeting”)
to be duly called and held as soon as reasonably practicable, but in no event later than February 1, 2014, for the purpose
of voting on the approval and adoption of an amendment to the Certificate of Incorporation of the Company providing that the shareholders
entitled to vote may take any action that they might have taken at a meeting of shareholders on written consent setting forth the
action so taken signed by the holders of outstanding shares having not less than the minimum number of votes that would be necessary
to authorize or take such action (the “Proposed Certificate Amendment”). The Company Board shall submit the
Proposed Certificate Amendment to its shareholders at the Company Shareholders' Meeting.

 

    	13

    	 

    

  

(b)              
The Company shall use its best efforts to prepare and file a proxy statement (the “Proxy Statement”) with the
Commission and shall use its best efforts to cause the Proxy Statement to be mailed to Company shareholders in advance of the Company
Shareholders' Meeting. The Company shall give the Purchaser and its counsel the opportunity to review the Proxy Statement and all
amendments and supplements thereto, prior to their being filed with the Commission. The Company will notify the Purchaser promptly
of the receipt of any comments from the Commission or its staff and of any request by the Commission or its staff for amendments
or supplements to the Proxy Statement or for additional information and will supply the Purchaser with copies of all correspondence
between the Company or any of its representatives, on the one hand, and the Commission, on the other hand, with respect to the
Proxy Statement. If at any time prior to the Company Shareholders' Meeting there shall occur any event that should be set forth
in an amendment or supplement to the Proxy Statement, the Company will promptly prepare and mail to its shareholders such an amendment
or supplement.

 

(c)               
None of the information supplied by the Company for inclusion or incorporation by reference in the Proxy Statement or any
amendment thereof or supplement thereto will, at the time the Proxy Statement or any amendment thereof or supplement thereto is
first mailed to the Company’s shareholders and at the time of the Company Shareholders' Meeting, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading. The Proxy Statement will be prepared in accordance
with and comply as to form in all material respects with the requirements of the Securities Exchange Act of 1934, as amended, and
the rules and regulations thereunder as in effect from time to time.

 

6.5             
 Series B Directors. The Company shall use its best efforts to cause
the rights granted to the Purchaser with respect to the nomination and appointment of the Series B Directors (as defined in the
Certificate of Amendment) under this Agreement and the Certificate of Amendment to inure to the benefit of Purchaser. Such efforts
on the part of the Company shall include, but not be limited to, the nomination and appointment of the Series B Directors. The
Company shall enter into separate indemnification agreements upon the election or appointment of such Series B Director, in the
form attached hereto as Exhibit G, with each such Series B Director.

 

7.                 
Miscellaneous.

 

7.1             
Survival of Warranties and Covenants. Unless otherwise set forth
in this Agreement, the representations and warranties of the Company and the Purchaser contained in or made pursuant to this Agreement
shall survive for twelve (12) months from the date hereof (the date that is twelve (12) months from the date hereof,
the “Survival Date”) regardless of any investigation made by the Purchaser or on its behalf. Notwithstanding
any provision to the contrary contained in this Agreement, with respect to claims for breaches of representations and warranties
contained in this Agreement, no party will be liable with respect thereto unless written notice of a possible claim with respect
to such breach is given by the party making such claim on or prior to the Survival Date, it being understood that so long as such
written notice is given on or prior to the Survival Date, such representations and warranties shall continue to survive until such
matter is resolved. All covenants and agreements contained herein shall survive until they are completed or no longer applicable
in accordance with the terms of this Agreement.

 

    	14

    	 

    

  

7.2             
Successors and Assigns. The terms and conditions of this Agreement
shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. The Purchaser shall be
permitted to assign its rights under this Agreement with the prior written consent of the Company, which shall not be unreasonably
withheld. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or
their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.

 

7.3             
Indemnification.

 

(a)               
The Company shall defend, protect, indemnify and hold harmless the Purchaser, and all of its officers, directors, employees,
affiliates and agents (including, without limitation, those retained in connection with the transactions contemplated by this Agreement)
(collectively, the “Purchaser Indemnitees”) from and against any and all actions, causes of action, suits, claims,
costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective of whether any such Purchaser
Indemnitee is a party to the action for which indemnification hereunder is sought), including reasonable attorneys’ fees
and disbursements (the “Indemnified Liabilities”), incurred by the Purchaser Indemnitees or any of them as a
result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by
the Company in this Agreement or any of the agreements contemplated hereby, (b) any breach of any covenant, agreement or obligation
of the Company contained in this Agreement or any of the agreements contemplated hereby, or (c) the execution, delivery or
performance of this Agreement, any Agreements contemplated hereby including the Certificate of Amendment or the transactions contemplated
hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company
shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible
under applicable law. The indemnification provided for under this Subsection 7.3(a) shall not apply to any Indemnified
Liabilities arising out of the gross negligence or intentional misconduct of any Purchaser Indemnitee.

 

(b)              
The Purchaser shall defend, protect, indemnify and hold harmless the Company and all of its officers, directors, employees,
affiliates and agents (including, without limitation, those retained in connection with the transactions contemplated by this Agreement)
(collectively, the “Company Indemnitees”) from and against any and all Indemnified Liabilities incurred by the
Company Indemnitees or any of them as a result of, or arising out of, or relating to (a) any misrepresentation or breach of
any representation or warranty made by the Purchaser in this Agreement or any of the agreements contemplate hereby, or (b) any
breach of any covenant, agreement or obligation of the Purchaser contained in this Agreement or any of the agreements contemplated
thereby. To the extent that the foregoing undertaking by the Purchaser may be unenforceable for any reason, the Purchaser shall
make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under
applicable law. The indemnification provided for under this Subsection 7.3(b) shall not apply to any Indemnified Liabilities
arising out of the gross negligence or intentional misconduct of any Company Indemnitee.

 

    	15

    	 

    

  

(c)               
No amount shall be payable under this Section 7.3 unless the aggregate amount of all Indemnified Liabilities
otherwise payable by a party exceeds $100,000, in which event the entire amount of such Indemnified Liabilities shall
be payable from the first dollar.

 

7.4             
Governing Law. This Agreement shall be governed by and construed
in accordance with the laws in effect in the State of New York, without giving effect to its conflicts of law principles (other
than § 5-1401 of the New York General Obligations Law).

 

7.5             
Counterparts. This Agreement may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts
may be delivered via facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall
be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

7.6             
Titles and Subtitles. The titles and subtitles used in this Agreement
are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

7.7             
Notices. All notices and other communications given or made pursuant
to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (a) personal
delivery to the party to be notified, (b) when sent, if sent by electronic mail or facsimile during normal business hours
of the recipient, and if not sent during normal business hours, then on the recipient’s next business day, (c) five
(5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one
(1) business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day
delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as
set forth on the signature page, or to such e-mail address, facsimile number or address as subsequently modified by written notice
given in accordance with this Subsection 7.7. If notice is given to the Company, a copy shall also be sent to Graubard Miller,
405 Lexington Avenue, New York, New York 10174, Attn: David Alan Miller, Esq. and if notice is given to the Purchaser, a copy
shall also be given to Milbank, Tweed, Hadley & McCloy LLP, One Chase Manhattan Plaza, New York, New York 10005, Attn: Roland
Hlawaty, Esq.

 

7.8             
No Finder’s Fees. Except as set forth in Section 7.8 of the
Disclosure Schedule, each party represents that it neither is nor will be obligated for any finder’s fee or commission in
connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any
commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs
and expenses of defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees,
or representatives is responsible. The Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission
or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses
of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives
is responsible.

 

    	16

    	 

    

  

7.9             
Amendments and Waivers. Any term of this Agreement may be amended,
terminated or waived only with the written consent of the Company and (i) the holders of at least 50% of the then-outstanding
Shares. Any amendment or waiver effected in accordance with this Subsection 7.9 shall be binding upon the Purchaser and each
transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and
the Company.

 

7.10         
Severability. The invalidity or unenforceability of any provision
hereof shall in no way affect the validity or enforceability of any other provision.

 

7.11         
Delays or Omissions. No delay or omission to exercise any right,
power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement,
shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver
of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor
shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring.
Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement,
or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective
only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded
to any party, shall be cumulative and not alternative.

 

7.12         
Entire Agreement. This Agreement (including the Exhibits hereto)
and the Certificate of Amendment constitute the full and entire understanding and agreement between the parties with respect to
the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties
are expressly canceled.

 

7.13         
Dispute Resolution. The parties (a) hereby irrevocably and unconditionally
submit to the jurisdiction of the state courts of New York and to the jurisdiction of the United States District Court for the
District of Southern New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement,
(b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state
courts of New York or the United States District Court for the District of Southern New York, and (c) hereby waive, and agree
not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that
the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper
or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

 

[Signature
Page Follows]

 

    	17

    	 

    

  

IN WITNESS WHEREOF,
the parties have executed this Series B Preferred Stock Purchase Agreement as of the date first written above.

 

 

 

COMPANY:

 

FREDERICK’S OF HOLLYWOOD GROUP INC.

 

By:/s/ Thomas J. Lynch

 

Name:Thomas J. Lynch

 

Title:Chief Executive Officer

 

		Address:	6255 Sunset Blvd., 6th Floor

Hollywood, CA 90028

 

PURCHASER:

 

Five Island
Asset Management LLC

 

By:/s/ Philip A. Falcone

 

Name:Philip A. Falcone

 

Title:Chief Executive Officer

 

		Address:	c/o Harbinger Group Inc.

Attention: Gus Cheliotis 

450 Park Avenue, 30th Floor

New York, NY 10022

 

    	 

    	 

    

 

EXHIBIT A

 

FORM OF CERTIFICATE OF AMENDMENT

 

 

 

[See Exhibit
3.1 to Current Report on Form 8-K.]

 

    	 

    	 

    

 

EXHIBIT B

 

DISCLOSURE SCHEDULE

 

    	 

    	 

    

  

EXHIBIT C

 

FORM OF OPINION

 

GRAUBARD
MILLER

The Chrysler Building

405 Lexington Avenue

New York, NY 10174-1901

 

March 15, 2013

 

Five Island Asset Management LLC

c/o Harbinger Group Inc.

450 Park Avenue, 30th Floor

New York, NY 10022

 

Re: Frederick’s of Hollywood Group Inc.

Ladies and Gentlemen:

 

This opinion is being
furnished pursuant to Section 4.2 of the Series B Preferred Stock Purchase Agreement (the “Agreement”), by and
between Frederick’s of Hollywood Group Inc., a New York corporation (the “Company”), and Five Island Asset Management
LLC (the “Purchaser”). Capitalized terms used herein and not otherwise defined shall have the respective meanings ascribed
to them in the Agreement.

 

We have acted as counsel
to the Company in connection with the preparation, execution and delivery of the Agreement. As such counsel, we have examined and
are familiar with and have relied upon the following documents:

 

		(a)	the Restated Certificate of Incorporation and by-laws, each as amended to date, of the Company;

 

		(b)	a copy of the Agreement, the Warrants and the Certificate of Amendment (collectively, the “Transaction
Documents”); and

 

		(c)	such other records of meetings, documents, instruments and certificates (including but not limited
to certificates of public officials and officers of the Company) as we have considered necessary for purposes of this opinion.

 

In connection with
the above listed items, we have assumed the genuineness of all signatures and the authenticity of all documents submitted to us
as originals, the conformity to original documents of the documents submitted to us as certified, fax or photostatic copies and
the authenticity of the originals of such latter documents. As to all questions of fact material to this opinion that have not
been independently established, we have relied upon the certificates of officers of the Company and upon the representations and
warranties of the Company contained in the Agreement.

 

    	 

    	 

    

  

Based on the foregoing
and upon such investigation as we have deemed necessary, we give you our opinion as follows:

 

1.                 
The Company is a corporation duly organized under the laws of the State of New York. The Company is validly existing in
the State of New York

 

2.                 
The Company has the corporate power and authority to enter into and perform its obligations under each of the Transaction
Documents to which it is a party. The Company has the corporate power and authority to own, lease and operate its properties and
to carry on its business as it is now conducted.

 

3.                 
Each of the Transaction Documents to which the Company is a party have been duly authorized, executed and delivered by the
Company.

 

4.                 
Each of the Transaction Documents to which the Company is a party is a legally valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other
equitable remedies, or (iii) to the extent indemnification provisions may be limited by applicable federal or state securities
laws.

 

5.                 
The shares of Series B Preferred Stock being purchased under the Purchase Agreement are duly authorized and will be validly
issued, fully paid and nonassessable when paid for in accordance with the Purchase Agreement.

 

6.                 
The execution and delivery by the Company of each of the Transaction Documents to which it is a party, and the performance
by the Company of its obligations thereunder, will not (a) violate the Restated Certificate or by-laws of the Company, (b),
to our knowledge, violate any federal or New York law or governmental rule or regulation applicable to the Company, except as would
not have a Material Adverse Effect on the Company, or (c), to our knowledge, require any consents, approvals or authorizations
to be obtained by the Company from, or any registrations, declarations or filings to be made by the Company with, any Governmental
Authority under any federal or New York statute or regulation or the Business Corporation Law of the State of New York, applicable
to the Company on or prior to the date hereof, that have not been obtained or made, except for (i) the filing of the Certificate
of Amendment, which will have been filed as of the date hereof, (ii) the filing with the Commission of a Current Report on Form
8-K with respect to the transactions contemplated by the Transaction Documents, (iii) the written consent of the holders of at
least a majority of the outstanding Series A Preferred Stock and (iv)  filings pursuant to Regulation D of the Securities
Act, and applicable state securities laws.

 

7.                 
To our knowledge, the Company is not a party to, or expressly bound by, any judgment, injunction or decree of any court
or governmental authority which would restrict or interfere with the performance by it of its obligations under the Transaction
Documents to which it is a party.

 

    	 

    	 

    

  

8.                 
Assuming the accuracy of the representations and warranties of the Purchasers set forth in the Purchase Agreement, the offer
and sale of the shares of the Series B Preferred Equity under the terms and conditions set forth in the Purchase Agreement, is
exempt from the registration requirements of the Securities Act of 1933, as amended.

 

No opinion is expressed
herein other than as to the laws of the State of New York and the federal securities laws of the United States of America. Specifically,
we express no opinion with respect to (i) the law of any other state of the United States, and (ii) the law of any foreign
country, including any such law governing the issuance of securities in any such country.

 

Where an opinion is
qualified by our knowledge as to a certain matter relating to the Company, knowledge is deemed to be based on the actual knowledge
of those attorneys that are currently employed by this firm as of the date of this opinion who have been actively engaged on matters
for which we have been employed by the Company.

 

This opinion is addressed
solely to the Purchaser, and is being delivered to it. This opinion is solely for the benefit of the Purchaser and may not be relied
upon in any manner by any other person.

 

	Very truly yours,
	 
	/s/ GRAUBARD MILLER

 

    	 

    	 

    

 

EXHIBIT D

 

SECOND AMENDED AND RESTATED BY-LAWS

 

 

 

[See Exhibit
3.2 to Current Report on Form 8-K.]

 

    	 

    	 

    

 

EXHIBIT E

 

FORM OF WARRANT

 

 

 

[See Exhibits
10.2 – 10.7 to the Current Report on Form 8-K]

 

    	 

    	 

    

 

Exhibit F

 

 

EXHIBIT F

 

Additional
Agreement With Respect to Registration
Rights 

 

The registration rights
set forth in this Exhibit F to the Series B Preferred Stock Purchase Agreement (the “Agreement”) shall
be in addition to the rights set forth in Section 6.1 thereof. Capitalized terms not otherwise defined herein have the meanings
set forth in the Agreement.

 

W I T N E S S E T H :

 

		1.	Definitions. As used in this Exhibit F, the following
terms have the following meanings:

 

“Agreement”
has the meaning set forth in the introduction.

 

“Business
Day” means any day (other than a day which is a Saturday, Sunday or legal holiday in the States of New York) on which
banks are open for business in the States of New York.

 

“Delay
Period” has the meaning set forth in Section 2(d).

 

“Demand
Notice” has the meaning set forth in Section 2(a)(i).

 

“Demand
Registration” has the meaning set forth in Section 2(b).

 

“Effectiveness
Period” has the meaning set forth in Section 2(c).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated
thereunder.

 

“free writing
prospectus” shall have the meaning set forth in Rule 405 under the Securities Act.

 

“Indemnified
Party” shall have the meaning set forth in Section 7(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 7(c).

 

“Inspectors”
has the meaning set forth in Section 4(j).

 

“Interruption
Period” has the meaning set forth in Section 4.

 

“Losses”
has the meaning set forth in Section 7(a).

 

“Marketing
Materials” has the meaning set forth in Section 7(a).

 

“Other Securities”
has the meaning set forth in Section 2(a)(ii).

 

“Piggyback
Registration” has the meaning set forth in Section 3(a).

 

    	 

    	 

    

  

“Prospectus”
means the prospectus included in any Registration Statement (including a prospectus that discloses information previously omitted
from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A), as amended or supplemented
by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by
such Registration Statement and all other amendments and supplements to such prospectus, including post-effective amendments, and
all material incorporated by reference or deemed to be incorporated by reference in such prospectus, including any free writing
prospectus.

 

“Records”
has the meaning set forth in Section 4(j).

 

“Registration”
means registration under the Securities Act of an offering of Registrable Securities pursuant to a Demand Registration or a Piggyback
Registration.

 

“Registration
Statement” means any registration statement of the Company filed under the Securities Act that covers any of the
Registrable Securities pursuant to the provisions of this Agreement, including the related Prospectus, all amendments and supplements
to such registration statement, including pre- and post-effective amendments, all exhibits thereto and all material incorporated
by reference or deemed to be incorporated by reference in such registration statement. The term “Registration Statement”
shall also include any registration statement filed pursuant to Rule 462(b) to register additional securities in connection with
any offering.

 

“road show”
means any “road show” as defined in Rule 433 under the Securities Act, including an electronic road show.

 

“SEC”
means the Securities and Exchange Commission or any other governmental agency at the time administering the Securities Act.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder.

 

“Shelf Registration”
means the filing of a Registration Statement relating to Registrable Securities, to provide for the sale by the holders thereof
of the Registrable Securities from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act.

 

“underwritten
offering” means a registration under the Securities Act in which securities of the Company are sold to an underwriter
for reoffering to the public.

 

		2.	Demand Registration.

 

(a)               
(i)At any time after the date of the Agreement, the Purchaser shall have the right, by written notice given to the Company
(a “Demand Notice”), to request the Company to register under and in accordance with the provisions of
the Securities Act all or any portion of the Registrable Securities designated by the Purchaser; provided, however, that
the Purchaser shall only be entitled to two (2) Demand Registrations pursuant to the provisions of this Section 2(a)(i)
at any time where the Company is not eligible to use Form S-3 for the registration of Registrable Securities for resale unless
any Demand Registration does not become effective or is not maintained in effect for the respective periods set forth in Section
2(c), in which case the Purchaser will be entitled to an additional Demand Registration pursuant hereto. Provided that the
Company is eligible for use of Form S-3 (or any successor form), the Purchaser shall have the right to request the Company to register
under and, in accordance with, the provisions of the Securities Act all or any portion of the Registrable Securities.

 

    	2

    	 

    

  

(ii)In connection
with any Demand Registration in which holders of unregistered securities of the Company have a right or otherwise elect to participate
in the Demand Registration, and in the event that such Demand Registration involves an underwritten offering and the managing underwriter
or underwriters participating in such offering advise in writing that the total number of securities to be included in such offering
exceeds the amount that can be sold in (or during the time of) such offering without delaying or jeopardizing the success of such
offering (including the price per share of the Registrable Securities to be sold), then the Registrable Securities to be offered
should have priority over all other securities (the “Other Securities”) that may be included in
such offering, and any securities remaining after the Registrable Securities have been included in such offering shall be distributed
amongst the holders of the Other Securities pro rata according to each such holder’s overall percentage of ownership
in the Company. In the event of such a pro-rata distribution, to the extent that any holder (or holders) has not submitted a valid
demand notice, or withdraws from the underwriting, then those shares that would have been allocated pro-rata to the non-participating
holder if they had participated shall be distributed amongst the other participating holders, pro rata according to each
participating holder’s overall percentage of ownership in the Company.

 

(b)              
The Company, within sixty (60) days of the date on which the Company receives a Demand Notice given by the Purchaser in
accordance with Section 2(a), shall file with the SEC, and the Company shall thereafter use its best efforts to cause to
be declared effective as promptly as practicable, a Registration Statement on the appropriate form for the registration and sale,
in accordance with the intended method or methods of distribution, of the total number of Registrable Securities specified by the
Purchaser in such Demand Notice (a “Demand Registration”). Any Demand Registration may, at the request
of the Purchaser, be a Shelf Registration. Notwithstanding the foregoing, if the 60-day period shall expire after the 45th
day subsequent to the Company’s fiscal year end, the Company shall have until the later of (i) the last day of such 60-day
period and (ii) five (5) business days following the date the Company’s annual report on Form 10-K for such fiscal year is
filed to file such Registration Statement.

 

(c)               
The Company shall use commercially reasonable efforts to keep each Registration Statement filed pursuant to this Section
2 continuously effective and usable for the resale of the Registrable Securities covered thereby (i) in the case of a Registration
that is not a Shelf Registration, for a period of one hundred twenty (120) days from the date on which the SEC declares such Registration
Statement effective and (ii) in the case of a Shelf Registration, for a period of three (3) years from the date on which the SEC
declares such Registration Statement effective, in either case (x) until such earlier date as all of the securities covered by
such Registration Statement have been sold pursuant to such Registration Statement, and (y) as such period may be extended pursuant
to this Section 2. The time period for which the Company is required to maintain the effectiveness of any Registration Statement
shall be extended by the aggregate number of days of all Delay Periods and all Interruption Periods occurring with respect to such
Registration and such period and any extension thereof is hereinafter referred to as the “Effectiveness Period”.

 

    	3

    	 

    

  

(d)              
The Company shall be entitled to postpone the filing of any Registration Statement otherwise required to be prepared and
filed by the Company pursuant to this Section 2, or suspend the use of any effective Registration Statement under this Section
2, for a reasonable period of time (a “Delay Period”), if the Board of the Company determines in
good faith and in the Board’s reasonable judgment that the registration and distribution of the Registrable Securities covered
or to be covered by such Registration Statement would materially interfere with any pending material financing, acquisition or
corporate reorganization or other material corporate development involving the Company or any of its subsidiaries or would require
premature disclosure thereof and promptly gives the Purchaser written notice of such determination, containing a general statement
of the reasons for such postponement and an approximation of the period of the anticipated delay; provided, however, that
(i) the aggregate number of days included in all Delay Periods during any consecutive twelve (12) months shall not exceed the aggregate
of (x) forty-five (45) days minus (y) the number of days occurring during all Interruption Periods during such consecutive twelve
(12) months and (ii) a period of at least forty-five (45) days shall elapse between the termination of any Delay Period or Interruption
Period and the commencement of the immediately succeeding Delay Period. If the Company shall so postpone the filing of a Registration
Statement, the Purchaser shall have the right to withdraw the request for registration within forty-five (45) days after receipt
of the notice of postponement or, if earlier, the termination of such Delay Period (and, in the event of such withdrawal, such
request shall not be counted for purposes of determining the number of requests for registration to which the Purchaser is entitled
pursuant to this Section 2). The Company shall not be entitled to initiate or continue a Delay Period unless it shall (A)
concurrently prohibit sales by all other security holders under registration statements covering securities held by such other
security holders and (B) in accordance with the Company’s policies from time to time in effect, forbid purchases and sales
in the open market by directors and executive officers of the Company.

 

(e)               
The Company shall not include any securities (whether for its own account or otherwise) that are not Registrable Securities
in any Registration Statement filed pursuant to this Section 2 if inclusion of such securities results in a reduction in
the number of Registrable Securities that may be included in such Registration Statement without the prior written consent of the
Purchaser. Any such securities so included shall be subject to the cut-back provisions of Section 2(a)(ii).

 

(f)               
The Purchaser may, at any time prior to the effective date of the Registration Statement relating to such Registration,
revoke such request by providing a written notice to the Company revoking such request. Any such Demand Request so withdrawn shall
not be counted for purposes of determining the number of requests for registration to which the Purchaser is entitled pursuant
to this Section 2 if the Purchaser reimburses the Company for all its out-of-pocket expenses incurred in the preparation,
filing and processing of the Registration Statement; provided, however, that, if such revocation was based on (i) the Company’s
failure to comply in any material respect with its obligations hereunder or (ii) the institution by the Company of a Delay Period
or the occurrence of any Interruption Period, such reimbursement shall not be required.

 

    	4

    	 

    

  

		3.	Piggyback Registration.

 

(a)               
Right to Piggyback. If at any time the Company proposes to file a registration statement under the Securities Act
with respect to a public offering by the Company for its own account of securities of the same type as the Registrable Securities
(other than a registration statement (i) on Form S-8 or Form S-4 or any successor forms thereto, or (ii) filed solely in connection
with a dividend reinvestment plan or an employee benefit plan covering only officers or directors of the Company or its Affiliates),
then the Company shall give written notice of such proposed filing to the Purchaser at least fifteen (15) days before the anticipated
filing date. Such notice shall offer the Purchaser the opportunity to register such amount of Registrable Securities as it may
request (a “Piggyback Registration”). Subject to Section 3(b), the Company shall include in each
such Piggyback Registration all Registrable Securities with respect to which the Company has received written requests for inclusion
therein within five (5) days after notice has been given to the Purchaser. The Purchaser shall be permitted to withdraw all or
any portion of the Registrable Securities from a Piggyback Registration at any time prior to the effective date of such Piggyback
Registration.

 

(b)              
Priority on Piggyback Registrations. The Company shall permit the Purchaser to include all such Registrable Securities
on the same terms and conditions as any similar securities, if any, of the Company or any other persons included therein. Notwithstanding
the foregoing, if the Company or the managing underwriter or underwriters participating in such offering advise the Purchaser in
writing that the total amount of securities requested to be included in such Piggyback Registration exceeds the amount which can
be sold in (or during the time of) such offering without delaying or jeopardizing the success of the offering (including the price
per share of the securities to be sold), then the amount of securities to be offered for the account of the Purchaser and other
holders of securities who have piggyback registration rights with respect thereto shall be reduced pro rata on the basis of the
number of Common Stock equivalents requested to be registered by each Purchaser or other holder participating in such offering.

 

4.                 
Registration Procedures. In connection with the registration obligations of
the Company pursuant to and in accordance with Sections 2 and 3 (and subject to Sections 2 and 3),
the Company shall use reasonable best efforts to effect such registration to permit the sale of such Registrable Securities in
accordance with the intended method or methods of disposition thereof, and pursuant thereto the Company shall as expeditiously
as possible:

 

(a)               
prepare and file with the SEC a Registration Statement for the sale of the Registrable Securities on any form for which
the Company then qualifies or which counsel for the Company shall deem appropriate in accordance with the Purchaser’s intended
method or methods of distribution thereof, and use reasonable best efforts to cause such Registration Statement to become effective
and remain effective as provided herein;

 

(b)              
prepare and file with the SEC such amendments (including post-effective amendments) to such Registration Statement, and
such supplements to the related Prospectus, as may be required by the rules, regulations or instructions applicable to the Securities
Act during the applicable period in accordance with the intended methods of disposition specified by the Purchaser, make generally
available earnings statements satisfying the provisions of Section 11(a) of the Securities Act (provided that the Company
shall be deemed to have complied with this Section if it has complied with Rule 158 under the Securities Act), and cause the related
Prospectus as so supplemented to be filed pursuant to Rule 424 under the Securities Act; provided, however, that before
filing a Registration Statement or Prospectus, or any amendments or supplements thereto (other than reports required to be filed
by it under the Exchange Act that are incorporated or deemed to be incorporated by reference into the Registration Statement and
the Prospectus except to the extent that such reports related primarily to the offering), the Company shall furnish to the Purchaser
and its counsel for review and comment, copies of all documents required to be filed;

 

    	5

    	 

    

  

(c)               
notify the Purchaser promptly and (if requested) confirm such notice in writing, (i) when a Prospectus or any Prospectus
supplement or post-effective amendment has been filed, and, with respect to such Registration Statement or any post-effective amendment,
when the same has become effective, (ii) of any request by the SEC for amendments or supplements to such Registration Statement
or the related Prospectus or for additional information regarding the Company or the Purchaser, (iii) of the issuance by the SEC
of any stop order suspending the effectiveness of such Registration Statement or the initiation of any proceedings for that purpose,
(iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification
of any of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose,
and (v) of the happening of any event that requires the making of any changes in such Registration Statement, Prospectus or documents
incorporated or deemed to be incorporated therein by reference so that they will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading;

 

(d)              
use reasonable best efforts to prevent the issuance of any order suspending the effectiveness of such Registration Statement
or the qualification or exemption from qualification of any Registrable Securities for sale in any jurisdiction in the United States,
and to obtain the lifting or withdrawal of any such order at the earliest practicable time;

 

(e)               
furnish to the Purchaser and its counsel and each managing underwriter, if any, without charge, one conformed copy of such
Registration Statement, as declared effective by the SEC, and of each post-effective amendment thereto, in each case including
financial statements and schedules and all exhibits and reports incorporated or deemed to be incorporated therein by reference;
and deliver, without charge, such number of copies of the preliminary prospectus, any amended preliminary prospectus, any free
writing prospectus, each final Prospectus and any post-effective amendment or supplement thereto, as the Purchaser may reasonably
request in order to facilitate the disposition of the Registrable Securities of the Purchaser covered by such Registration Statement
in conformity with the requirements of the Securities Act;

 

(f)               
prior to any public offering of Registrable Securities covered by such Registration Statement, use its reasonable best efforts
to register or qualify such Registrable Securities for offer and sale under the securities or “Blue Sky” laws of such
jurisdictions as the Purchaser shall reasonably request in writing; provided, however, that the Company shall in no event
be required to qualify generally to do business as a foreign corporation or as a dealer in any jurisdiction where it is not at
the time required to be so qualified or to execute or file a general consent to service of process in any such jurisdiction where
it has not theretofore done so or to take any action that would subject it to general service of process or taxation in any such
jurisdiction where it is not then subject;

 

    	6

    	 

    

  

(g)              
upon the occurrence of any event contemplated by Section 4(c)(v), prepare a supplement or post-effective amendment
to such Registration Statement or the related Prospectus or any document incorporated or deemed to be incorporated therein by reference
and file any other required document so that, as thereafter delivered to the purchasers of the Registrable Securities being sold
thereunder (including upon the termination of any Delay Period), such Prospectus will not contain an untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading;

 

(h)              
use reasonable best efforts to cause all Registrable Securities covered by such Registration Statement to be listed on each
securities exchange or automated interdealer quotation system, if any, on which similar securities issued by the Company are then
listed or quoted, or, if none, on such securities exchange or automated interdealer quotation system reasonably selected by the
Company;

 

(i)                
on or before the effective date of such Registration Statement, provide the transfer agent of the Company for the Registrable
Securities with printed certificates for the Registrable Securities covered by such Registration Statement, which are in a form
eligible for deposit with The Depository Trust Company, unless such securities will be issued in book entry only form;

 

(j)                
if such offering is an underwritten offering, make available for inspection by the Purchaser, any underwriter participating
in any offering pursuant to such Registration Statement, and any attorney, accountant or other agent retained by the Purchaser
or underwriter (collectively, the “Inspectors”), all financial and other records and other information,
pertinent corporate documents and properties of any of the Company and its subsidiaries and affiliates (collectively, the “Records”),
as shall be reasonably necessary to enable them to exercise their due diligence responsibilities; provided, however, that
the Records that the Company determines, in good faith, to be confidential and which it notifies the Inspectors in writing are
confidential shall not be disclosed to any Inspector unless such Inspector signs a confidentiality agreement reasonably satisfactory
to the Company, which shall permit the disclosure of such Records in such Registration Statement or the related Prospectus if (i)
necessary to avoid or correct a material misstatement in or material omission from such Registration Statement or Prospectus or
(ii) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction; provided
further, however, that (A) any decision regarding the disclosure of information pursuant to subsection (i) shall be made only
after consultation with counsel for the applicable Inspectors and the Company and (B) with respect to any release of Records pursuant
to subsection (ii), the Purchaser agrees that it shall, promptly after learning that disclosure of such Records is sought in a
court having jurisdiction, give notice to the Company so that the Company, at the Company’s expense, may undertake appropriate
action to prevent disclosure of such Records;

 

(k)              
not later than the effective date of a registration statement, the Company shall provide to the Purchaser the CUSIP number
for all Registrable Securities; and

 

    	7

    	 

    

  

(l)                
if such offering is an underwritten offering, enter into such agreements (including an underwriting agreement in form, scope
and substance as is customary in underwritten offerings) and take all such other appropriate and reasonable actions requested by
the Purchaser (including those reasonably requested by the managing underwriters) in order to expedite or facilitate the disposition
of such Registrable Securities, and in such connection, (i) use reasonable best efforts to obtain opinions of counsel to the Company
and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing
underwriters and counsel to the Purchaser), addressed to the Purchaser and each of the underwriters as to the matters customarily
covered in opinions requested in underwritten offerings and such other matters as may be reasonably requested by such counsel and
underwriters, (ii) use reasonable best efforts to obtain “cold comfort” letters and updates thereof from the independent
certified public accountants of the Company (and, if necessary, any other independent certified public accountants of any subsidiary
of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required
to be, included in the Registration Statement), addressed to each selling holder of Registrable Securities covered by the Registration
Statement (unless such accountants shall be prohibited from so addressing such letters by applicable standards of the accounting
profession) and each of the underwriters, such letters to be in customary form and covering matters of the type customarily covered
in “cold comfort” letters in connection with underwritten offerings, (iii) if requested and if an underwriting agreement
is entered into, provide indemnification provisions and procedures customary for underwritten public offerings, but in any event
no less favorable to the indemnified parties than the provisions set forth in Section 7, (iv) allow, and provide for, Purchaser’s
participation in road shows, management presentations, investor meetings and other customary participation in connection therewith,
and (v) provide for the reasonable participation and cooperation by the management of the Company with respect thereto, including
participation by management in road shows, investor meetings and other customary cooperation. The above shall be done at each closing
under such underwriting or similar agreement, or as and to the extent required thereunder.

 

The Company may require
the Purchaser to furnish such information regarding the Purchaser and its intended method of disposition of such Registrable Securities
as it may from time to time reasonably request in writing. Notwithstanding the foregoing, in no event shall the Purchaser be required
to provide any information about its investors unless required by the SEC to do so.

 

The Purchaser agrees
that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 4(c)(ii),
4(c)(iii), 4(c)(iv) or 4(c)(v), that it shall discontinue disposition of any Registrable Securities covered
by such Registration Statement or the related Prospectus until receipt of the copies of the supplemented or amended Prospectus
contemplated by Section 4(g), or until it is advised in writing by the Company that the use of the applicable Prospectus
may be resumed, and has received copies of any amended or supplemented Prospectus or any additional or supplemental filings which
are incorporated, or deemed to be incorporated, by reference in such Prospectus (such period during which disposition is discontinued
being an “Interruption Period”) and, if requested by the Company, the Purchaser shall deliver to the
Company (at the expense of the Company) all copies then in its possession, other than permanent file copies then in such holder’s
possession, of the Prospectus covering such Registrable Securities at the time of receipt of such request.

 

    	8

    	 

    

  

5.                 
Registration Expenses. Whether or not any Registration Statement is filed
or becomes effective, the Company shall pay all costs, fees and expenses incident to the Company’s performance of or compliance
with this Agreement, including (i) all registration and filing fees, including FINRA filing fees, (ii) all fees and expenses of
compliance with securities or “Blue Sky” laws, including reasonable fees and disbursements of counsel in connection
therewith, (iii) printing expenses (including expenses of printing certificates for Registrable Securities and of printing prospectuses
if the printing of prospectuses is requested by the Purchaser or the managing underwriter, if any) and expenses associated with
a road show, (iv) messenger, telephone and delivery expenses, (v) fees and disbursements of counsel for the Company, (vi) fees
and disbursements of all independent certified public accountants of the Company (including expenses of any “cold comfort”
letters required in connection with this Agreement) and all other persons retained by the Company in connection with such Registration
Statement, (vii) fees and disbursements of one counsel, other than the Company’s counsel, selected by the Purchaser, (viii)
in the event of an underwritten offering, the expenses of the Company and the underwriters associated with any “road show”
which are customarily paid or reimbursed by issuers and (ix) all other costs, fees and expenses incident to the Company’s
performance or compliance with this Agreement. The Company shall have no obligation to pay any underwriting discounts or selling
commissions attributable to the Registrable Securities being sold by the holders thereof, which underwriting discounts or selling
commissions shall be borne by such holders. Additionally, in an underwritten offering, all selling shareholders and the Company
shall bear the fees and expenses of the underwriters pro rata in proportion to the respective amount of shares each is selling
in such offering.

 

6.Underwriting
Requirements.

 

(a)               
Subject to Section 6(c), the Purchaser shall have the right, by written notice, to request that any Demand Registration
provide for an underwritten offering.

 

(b)              
In the case of any underwritten offering pursuant to a Demand Registration, the Purchaser shall select the institution or
institutions that shall manage or lead such offering. In the case of any underwritten offering pursuant to a Piggyback Registration,
the Company shall select the institution or institutions that shall manage or lead such offering.

 

(c)               
In the case of any Piggyback Registration that is an underwritten offering, the Purchaser shall not be entitled to participate
in an underwritten offering unless and until it has entered into an underwriting or other agreement with such institution or institutions
for such offering in such form as the Company and such institution or institutions shall reasonably determine; provided,
that the Purchaser shall not be required to make any representation or warranties to the Company or the underwriters (other than
representations and warranties regarding itself and its ownership of the shares to be sold pursuant to such underwriting) or to
undertake any indemnification or contribution obligations to the Company or any underwriter with respect thereto, other than as
specifically provided in Section 7.

 

7.Indemnification.

 

(a)               
Indemnification by the Company. The Company shall, without limitation as to time, indemnify and hold harmless,
to the fullest extent permitted by law, the Purchaser and its officers, directors and agents and employees, each Person who controls
the Purchaser (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors,
agents and employees of each such controlling person, to the fullest extent lawful, from and against any and all losses, claims,
damages, liabilities, judgment, costs (including costs of investigation or preparation and reasonable attorneys’ fees) and
expenses (collectively, “Losses”), as incurred, arising out of or based upon (w) any untrue or alleged
untrue statement of a material fact contained in such Registration Statement or Prospectus or in any amendment or supplement thereto
in any preliminary prospectus, any free writing prospectus, any information the Company has filed or is required to file pursuant
to Rule 433(d) under the Securities Act, or any other material or information provided to or made available to investors by, or
with the approval of, the Company in connection with the offering, including any road show for the offering (collectively, “Marketing
Materials”), (x) any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein not misleading, except insofar as the same are based upon information furnished in writing to the Company
by or on behalf of the Purchaser expressly for use in the Marketing Materials, (y) any untrue statement or alleged untrue statement
of a material fact in the information conveyed to any purchaser at the time of the sale to such purchaser, or the omission or alleged
omission to state therein a material fact required to be stated therein, or (z) any violation by the Company of any federal, state
or common law rule or regulation applicable to the Company and relating to action required of or inaction by the Company in connection
with any such registration; provided, however, that the Company shall not be liable to the Purchaser to the extent that
any such Losses arise out of or are based upon an untrue statement or alleged untrue statement or omission or alleged omission
made in any preliminary prospectus if (i) having previously been furnished by or on behalf of the Company with copies of the Prospectus,
the Purchaser failed to send or deliver a copy of the Prospectus with or prior to the delivery of written confirmation of the sale
of Registrable Securities by the Purchaser to the person asserting the claim from which such Losses arise and (ii) the Prospectus
would have corrected in all material respects such untrue statement or alleged untrue statement or such omission or alleged omission;
and provided further, however, that the Company shall not be liable in any such case to the extent that any such Losses
arise out of or are based upon an untrue statement or alleged untrue statement or omission or alleged omission in the Prospectus,
if (A) such untrue statement or alleged untrue statement, omission or alleged omission is corrected in all material respects in
an amendment or supplement to the Prospectus and (B) having previously been furnished by or on behalf of the Company with copies
of the Prospectus as so amended or supplemented, the Purchaser thereafter fails to deliver such Prospectus as so amended or supplemented,
prior to or concurrently with the sale of Registrable Securities.

 

    	9

    	 

    

  

(b)              
Indemnification by the Purchaser. In connection with any Registration Statement in which the Purchaser is
participating, the Purchaser shall furnish to the Company in writing such information as the Company reasonably requests for use
in connection with the Marketing Materials and agrees to indemnify, to the full extent permitted by law, the Company, its directors,
officers, agents or employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and
Section 20 of the Exchange Act) and the directors, officers, agents or employees of such controlling Persons, from and against
all Losses arising out of or based upon (x) any untrue or alleged untrue statement of a material fact contained in the Marketing
Materials or (y) any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading, to the extent, but only to the extent, that such untrue or alleged untrue statement or omission or alleged
omission is based upon and is consistent with information so furnished in writing by or on behalf of it to the Company expressly
for use in such Marketing Materials. The Purchaser shall not be held liable for any damages in excess of the total amount of proceeds
received from the sale of the Registrable Securities sold by it (net of all underwriting discounts and commissions) under that
particular Registration Statement.

 

    	10

    	 

    

  

(c)               
Conduct of Indemnification Proceedings. If any Person shall be entitled to indemnity hereunder (an “Indemnified
Party”), such Indemnified Party shall give prompt notice to the party from which such indemnity is sought (the “Indemnifying
Party”) of any claim or of the commencement of any proceeding with respect to which such Indemnified Party seeks
indemnification or contribution pursuant hereto; provided, however, that the delay or failure to so notify the Indemnifying
Party shall not relieve the Indemnifying Party from any obligation or liability except to the extent that the Indemnifying Party
has been materially prejudiced by such delay or failure. The Indemnifying Party shall have the right, exercisable by giving written
notice to an Indemnified Party promptly after the receipt of written notice from such Indemnified Party of such claim or proceeding,
to assume, at the Indemnifying Party’s expense, the defense of any such claim or proceeding, with counsel reasonably satisfactory
to such Indemnified Party; provided, however, that (i) an Indemnified Party shall have the right to employ separate counsel
in any such claim or proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party unless: (1) the Indemnifying Party agrees to pay such fees and expenses; (2) the Indemnifying
Party fails promptly to assume the defense of such claim or proceeding or fails to employ counsel reasonably satisfactory to such
Indemnified Party; or (3) the named parties to any proceeding (including impleaded parties) include both such Indemnified Party
and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that there may be one or more legal defenses
available to it that are in addition to or are inconsistent with those available to the Indemnifying Party or that a conflict of
interest is likely to exist among such Indemnified Party and any other indemnified parties (in which case the Indemnifying Party
shall not have the right to assume the defense of such action on behalf of such Indemnified Party); and (ii) subject to subsection
(3) above, the Indemnifying Party shall not, in connection with any one such claim or proceeding or separate but substantially
similar or related claims or proceedings in the same jurisdiction, arising out of the same general allegations or circumstances,
be liable for the fees and expenses of more than one firm of attorneys (together with appropriate local counsel) at any time for
all of the indemnified parties. Whether or not such defense is assumed by the Indemnifying Party, such Indemnified Party shall
not be subject to any liability for any settlement made without its consent, which consent shall not be unreasonably withheld,
conditioned or delayed. The Indemnifying Party shall not consent to entry of any judgment or enter into any settlement that does
not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release, in
form and substance reasonably satisfactory to the Indemnified Party, from all liability in respect of such claim or litigation
for which such Indemnified Party would be entitled to indemnification hereunder.

 

(d)              
Contribution. If the indemnification provided for in this Section 7 is applicable in accordance with
its terms but is legally unavailable to an Indemnified Party in respect of any Losses, then each applicable Indemnifying Party,
in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result
of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party, on the one hand,
and such Indemnified Party, on the other hand, in connection with the actions, statements or omissions that resulted in such Losses
as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party, on the one hand, and Indemnified
Party, on the other hand, shall be determined by reference to, among other things, whether any action in question, including any
untrue statement of a material fact or omission or alleged omission to state a material fact, has been taken by, or relates to
information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access
to information and opportunity to correct or prevent any such action, statement or omission. The amount paid or payable by a party
as a result of any Losses shall be deemed to include any legal or other fees or expenses incurred by such party in connection with
any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this
Section 7(d) were determined by pro rata allocation or by any other method of allocation that does not take account of the
equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provision of this Section 7(d),
the Purchaser shall not be required to contribute any amount which is in excess of the amount by which the total proceeds received
from the sale of the Registrable Securities sold by it (net of all underwriting discounts and commissions) exceeds the amount of
any damages that it has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

 

    	11

    	 

    

  

8.Rule
144 Information. With a view to making available the benefits of certain rules and regulations of the Commission which may
at any time permit the sale of the Registrable Securities to the public without registration, the Company agrees to use its reasonable
best efforts to:

 

(a)               
make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act,
at all times for so long as the Company remains subject to the periodic reporting requirements under Section 13 or 15(d) of the
Exchange Act;

 

(b)              
file with the Commission in a timely manner all reports and other documents required of the Company under the Securities
Act and the Exchange Act; and

 

(c)               
furnish to the Purchaser forthwith upon request a written statement by the Company as to its compliance with the reporting
requirements of the Securities Act and the Exchange Act , a copy of the most recent annual or quarterly report of the Company,
and such other reports and documents of the Company and other information in as the Purchaser may reasonably request in availing
itself of any rule or regulation of the Commission allowing it to sell any such securities without registration.

 

9.Miscellaneous.

 

(a)               
Specific Performance. The Company acknowledges and agrees that (a) irreparable damages would occur in the
event that any of the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached
and (b) remedies at law would not be adequate to compensate the non-breaching party. Accordingly, the Company agrees that the Purchaser
shall have the right, in addition to any other rights and remedies existing in its favor, to an injunction or injunctions to prevent
breaches of this Agreement and to enforce its rights hereunder. The right to equitable relief, including an injunction shall not
be limited by any other provision of this Agreement. In any action or proceeding against it seeking an injunction or other equitable
relief to enforce the provisions of this Agreement, the Company hereby (i) waives and agrees not to assert any defense that an
adequate remedy exists at law or that the Purchaser would not be irreparably harmed and (ii) waives and agrees not to seek any
requirement for the posting of any bond or other security in connection with any such action or proceeding.

 

    	12

    	 

    

  

(b)              
Time of the Essence; Calculation of Time Periods. The parties agree that time shall be of the essence in the
performance of the Company’s obligations hereunder. Except as otherwise indicated, all periods of time referred to herein
shall include all Saturdays, Sundays and holidays; provided, however, that if the date to perform the act or give any notice
with respect to this Agreement shall fall on a day other than a Business Day, such act or notice may be timely performed or given
if performed or given on the next succeeding Business Day.

 

(c)               
Transferability of Rights Hereunder. The Purchaser shall have the right to transfer any or all of its rights
hereunder to any purchaser or transferee of Registrable Securities, whereupon such purchaser or transferee shall have all of the
benefits of contained herein.

 

    	13

    	 

    

   

EXHIBIT G

 

FORM OF INDEMNIFICATION AGREEMENT

 

 

 

[See Exhibit
10.8 to Current Report on Form 8-K.]

 

    	14EXHIBIT 10.2

 

THE SECURITIES REPRESENTED BY THIS WARRANT
HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”). THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT (THE “WARRANT SHARES”)
MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE SECURITIES ACT OR UNDER
STATE SECURITIES LAWS. THIS WARRANT AND THE WARRANT SHARES MAY NOT BE PLEDGED, SOLD, ASSIGNED, TRANSFERRED OR OTHERWISE DISPOSED
OF EXCEPT PURSUANT TO THE EXPRESS PROVISIONS OF THIS WARRANT, AND NO SALE, ASSIGNMENT, TRANSFER, OR OTHER DISPOSITION OF THIS WARRANT
SHALL BE VALID OR EFFECTIVE UNLESS AND UNTIL SUCH PROVISIONS SHALL HAVE BEEN COMPLIED WITH.

 

Date of Issuance: March 15, 2013

 

FREDERICK’S OF HOLLYWOOD GROUP INC.

 

Common Stock Purchase Warrant

 

Void after June 23, 2015

 

Frederick’s of
Hollywood Group Inc., a New York corporation (the “Company”), for value received, hereby certifies and
agrees that Five Island Asset Management LLC or its registered assigns (the “Registered Holder”), is
entitled, subject to the terms set forth below, to purchase from the Company, on or after the date hereof (the “Date
of Issuance”) and on or before June 23, 2015 at not later than 5:00 p.m. New York time, five hundred thousand
(500,000) duly authorized, validly issued, fully paid and nonassessable shares of the Company’s common stock, $0.01 par value
per share (the “Common Stock”) at an initial exercise price equal to $0.45 per share, in each case,
subject to adjustment in certain cases as described herein. The shares purchasable upon exercise of this Warrant, and the purchase
price per share, are hereinafter referred to as the “Warrant Shares” and the “Exercise Price,”
respectively. The term “Warrant” as used herein shall include this Warrant and any other warrants delivered
in substitution or exchange therefor, as provided herein.

 

This Warrant is issued
pursuant to that certain Series B Preferred Stock Purchase Agreement of even date herewith between the Company and the Registered
Holder (the “Purchase Agreement”). The Warrant Shares are entitled to the benefits of the registration
rights set forth in the Purchase Agreement and the annexes and exhibits thereto.

 

    	 

    	 

    

 

 

1.                 
Exercise.

 

1.1             
Method of Exercise.

 

(a)               
Reference is hereby made to that certain common stock purchase warrant, dated as of May 23, 2012, issued by the Company
with an initial exercise price of $0.45 and a maturity date of May 23, 2015 (the “Corresponding Warrant”).
This Warrant may only be exercised by the Registered Holder, in whole or in part, (x) upon the exercise of the Corresponding Warrant
by the holder thereof and (y) by surrendering this Warrant, with a Notice of Exercise in the form of Annex A hereto duly
executed by such Registered Holder or by such Registered Holder’s duly authorized attorney, at the principal office of the
Company set forth in Section 10 hereof, or at such other office or agency as the Company may designate in writing pursuant to Section
10 hereof, accompanied by payment in full with good, cleared funds, in lawful money of the United States, of the Exercise Price
payable in respect of the number of shares of Warrant Shares purchased upon such exercise or by a cashless exercise pursuant to
Section 1.2 below.

 

(b)              
The Company shall provide written notice to the Registered Holder of this Warrant immediately upon the receipt of any notice
of exercise relating to the Corresponding Warrant.

 

(c)               
Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the date
of its surrender as provided in Section 1.1(a) hereof. At such time, the person or persons in whose name or names any certificates
for Warrant Shares shall be issuable upon such exercise as provided in Section 1.1(d) hereof shall be deemed to have become the
holder or holders of record of the Warrant Shares represented by such certificates.

 

(d)              
As soon as practicable after the exercise of this Warrant, in full or in part, and in any event within ten (10) days thereafter,
the Company, at its expense, will cause to be issued in the name of, and delivered to, the Registered Holder, or as such Registered
Holder (upon payment by such Registered Holder of any applicable transfer taxes) may direct.

 

(i)                
a certificate or certificates for the number of full Warrant Shares to which such Registered Holder shall be entitled upon
such exercise (or evidence that such Warrant Shares have been issued in the name of the Registered Holder in book entry form) plus,
in lieu of any fractional share to which such Registered Holder would otherwise be entitled, cash in an amount determined pursuant
to Section 3 hereof; and

 

(ii)              
in case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, representing in
the aggregate on the face or faces thereof the number of Warrant Shares equal (without giving effect to any adjustment therein)
to the number of such shares called for on the face of this Warrant minus the number of such shares purchased by the Registered
Holder upon such exercise as provided herein.

 

1.2             
Cashless Exercise of Warrant. In addition to the method of payment set forth in Section 1.1 and in lieu of
any cash payment required thereunder, the Registered Holder may elect to receive the number of shares of Common Stock equal to
the product of (x) the number of Warrant Shares multiplied by (y) a fraction, the numerator of which is the Market Value (as defined
below) of the Common Stock less the Exercise Price and the denominator of which is such Market Value. As used herein, the phrase
“Market Value” at any date shall be deemed to be the volume weighted average of the last reported sale
prices of the Common Stock for the last ten (10) Trading Days prior to the date of exercise, as officially reported by the principal
securities exchange on which the Common Stock is listed or admitted to trading, or, if the Common Stock is traded “over
the counter”, by a quotation system (including the pink sheets or Nasdaq OTC Electronic Bulletin Board) covering such trades
or if the Common Stock is not listed or admitted to trading on any national securities exchange or sold “over the counter,”
the average closing bid price as furnished by the Financial Industry Regulatory Authority through Nasdaq or similar organization
if Nasdaq is no longer reporting such information, or if the Common Stock is not quoted on Nasdaq or traded “over the counter,”
as determined in good faith by resolution of the Board of Directors of the Company (the “Board of Directors”),
based on the best information available to it. “Trading Day” shall mean a day during which trading in
securities generally occurs in the applicable securities market or on the principal securities exchange or bulletin board on which
the Common Stock is then traded, listed or quoted.

 

    	2

    	 

    

 

 

2.                 
Shares to be Fully Paid; Reservation of Shares. The Company covenants that all shares of Common Stock which
may be issued upon the exercise of the rights represented by this Warrant will, upon issuance by the Company, be duly and validly
issued, fully paid and nonassessable, and free from preemptive rights and free from all taxes, liens, duties and charges with
respect thereto and, in addition, the Company covenants that it will from time to time take all such action as may be requisite
to assure that the par value per share of the Common Stock is at all times equal to or less than the effective Exercise Price.
The Company further covenants that, from and after the Date of Issuance and during the period within which the rights represented
by this Warrant may be exercised, the Company will at all times have authorized and reserved, free from preemptive rights, out
of its authorized but unissued shares of Common Stock, solely for the purpose of effecting the exercise of this Warrant, a sufficient
number of shares of Common Stock to provide for the exercise of the rights represented by this Warrant. If at any time the number
of authorized but unissued shares of Common Stock shall not be sufficient to effect the exercise of this Warrant, the Company
shall take any and all corporate action as is necessary to increase its authorized but unissued shares of Common Stock to such
number of shares as shall be sufficient for such purpose. The Company will take all such action within its control as may be necessary
on its part to assure that all such shares of Common Stock may be so issued without violation of any applicable law or regulation,
or of any requirements of any national securities exchange upon which the Common Stock of the Company may be listed.

 

3.                 
Fractional Shares. The Company shall not be required upon the exercise of this Warrant to issue any fractional
shares, but shall make an adjustment therefor in cash on the basis of the Market Value for each fractional share of the Company’s
Common Stock which would be issuable upon exercise of this Warrant.

 

4.                 
Requirements for Transfer.

 

(a)               
Warrant Register. The Company will maintain a register (the “Warrant Register”) containing
the names and addresses of the Registered Holder or Registered Holders. Any Registered Holder of this Warrant or any portion thereof
may change its address as shown on the Warrant Register by written notice to the Company requesting such change, and the Company
shall promptly make such change. Until this Warrant is transferred on the Warrant Register of the Company, the Company may treat
the Registered Holder as shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding
any notice to the contrary, provided, however, that if and when this Warrant is properly assigned in blank, the Company may, but
shall not be obligated to, treat the bearer hereof as the absolute owner hereof for all purposes, notwithstanding any notice to
the contrary.

 

    	3

    	 

    

  

(b)              
Warrant Agent. The Company may, by written notice to the Registered Holder, appoint an agent for the purpose of maintaining
the Warrant Register referred to in Section 4(a) hereof, issuing the Common Stock issuable upon the exercise of this Warrant, exchanging
this Warrant, replacing this Warrant or any or all of the foregoing. Thereafter, any such registration, issuance, exchange, or
replacement, as the case may be, may be made at the office of such agent.

 

(c)               
Transfer. Subject to the provisions of applicable securities laws and this Section 4, this Warrant and all rights
hereunder are transferable, in whole or in part, upon the surrender of this Warrant with a properly executed Assignment Form in
substantially the form attached hereto as Annex B (the “Assignment”) at the principal office of
the Company.

 

(d)              
Exchange of Warrant Upon a Transfer. On surrender of this Warrant for exchange, properly endorsed on the Assignment
and subject to the provisions of this Warrant and limitations on assignments and transfers as contained in this Section 4, the
Company at its expense shall issue to or on the order of the Registered Holder a new warrant or warrants of like tenor, in the
name of the Registered Holder or as the Registered Holder (on payment by the Registered Holder of any applicable transfer taxes)
may direct, for the number of shares issuable upon exercise hereof.

 

5.                 
Adjustments and Other Rights. The Exercise Price and the number of Warrant Shares issuable upon exercise
of this Warrant shall be subject to adjustment from time to time as follows; provided,
that if more than one subsection of this Section 5 is applicable to a single event, the subsection shall be applied that
produces the largest adjustment and no single event shall cause an adjustment under more than one subsection of this Section 5
so as to result in duplication.

 

5.1             
Stock Dividends – Split-Ups. If after the Date of Issuance, and subject to the provisions of Section
5.7 below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock,
or by a split-up of shares of Common Stock, or other similar event, then, on the effective date of such stock dividend, split-up
or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to
such increase in outstanding shares of Common Stock.

 

5.2             
Aggregation of Shares. If after the Date of Issuance, and subject to the provisions of Section 5.7, the number
of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of
shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split,
reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased
in proportion to such decrease in outstanding shares of Common Stock.

 

    	4

    	 

    

  

5.3             
Adjustments in Exercise Price. Whenever the number of shares of Common Stock purchasable upon the exercise
of the Warrants is adjusted, as provided in Sections 5.1 and 5.2 above, the Exercise Price shall be adjusted (to the nearest
cent) by multiplying such Exercise Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be
the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y)
the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.

 

5.4             
Replacement of Securities upon Reorganization, Etc

 

. In case of any reclassification
or reorganization of the outstanding shares of Common Stock (other than a change covered by Section 5.1 or 5.2 hereof or that solely
affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into
another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not
result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance
to another corporation or entity of all or substantially all of the assets or all or substantially all other property of the Company,
as an entirety or substantially as an entirety, in connection with which the Company is dissolved, the Registered Holder shall
thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and
in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the
rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
that the Registered Holder would have received if such Registered Holder had exercised his, her or its Warrant(s) immediately prior
to such event; and if any reclassification also results in a change in the number of shares of Common Stock covered by Section
5.1 or 5.2, then such adjustment shall be made pursuant to Sections 5.1, 5.2, 5.3 and this Section 5.4. The provisions of this
Section 5.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers.

 

5.5             
Other Events. For so long as the Registered Holder holds this Warrant
or any portion thereof, if any event occurs as to which the provisions of this Section 5 are not strictly applicable or, if
strictly applicable, would not, in the good faith judgment of the Board of Directors, fairly and adequately protect the purchase
rights of the Warrants in accordance with the essential intent and principles of such provisions, then the Board of Directors shall
make such adjustments in the application of such provisions, in accordance with such essential intent and principles, as shall
be reasonably necessary, in the good faith opinion of the Board of Directors, to protect such purchase rights as aforesaid. The
Exercise Price or the number of Warrant Shares into which this Warrant is exercisable shall not be adjusted in the event of a change
in the par value of the Common Stock or a change in the jurisdiction of incorporation of the Company.

5.6             
Adjustment Rules. Any adjustments pursuant to this Section 5
shall be made successively whenever an event referred to herein shall occur.

 

    	5

    	 

    

 

5.7             
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section
5, and Warrants issued after such adjustment may state the same Exercise Price and the same number of shares as is stated in the
Warrants initially issued pursuant to the Purchase Agreement. However, the Company may at any time in its sole discretion make
any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any
Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, shall
be in the form as so changed.

5.8             
Payment of Taxes. The Company will pay all taxes (other than taxes
based upon income) and other governmental charges that may be imposed with respect to the issue or delivery of shares of Common
Stock upon exercise of the Warrant, excluding any tax or other charge imposed in connection with any transfer involved in the issue
and delivery of shares of Common Stock in a name other than that in which the Warrants so exercised were registered.

6.                 
No Impairment. The Company will not, by amendment of its Certificate of Incorporation, as amended (the “Certificate
of Incorporation”), or through any reorganization, recapitalization, sale or transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant but will at all times in good faith carry out all such terms and take all such actions as
may be reasonably necessary or appropriate in order to protect the rights herein of the holder of this Warrant against dilution
or other impairment.

 

7.                 
Notices of Record Date, Etc. In case the Company shall take a record of the holders of its Common Stock (or
other stock or securities at the time deliverable upon the exercise of this Warrant) for the purpose of entitling or enabling
them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of stock of
any class or any other securities, or to receive any other right; or of any capital reorganization of the Company, any reclassification
of the capital stock of the Company, any consolidation or merger of the Company with or into another corporation (other than a
consolidation or merger in which the Company is the surviving entity), or any transfer of all or substantially all of the assets
of the Company; or of the voluntary or involuntary dissolution, liquidation or winding-up of the Company, then, and in each such
case, the Company will mail or cause to be mailed to the Registered Holder of this Warrant a notice specifying, as the case may
be, (i) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount
and character of such dividend, distribution or right, or (ii) the effective date on which such reorganization, reclassification,
consolidation, merger, transfer, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed,
as of which the holders of record of Common Stock (or such other stock or securities at the time deliverable upon the exercise
of this Warrant) shall be entitled to exchange their shares of Common Stock (or such other stock or securities) for securities
or other property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation
or winding-up. The Company will use commercially reasonable efforts to cause such notice to be mailed promptly, and in any event,
at least ten (10) business days prior to the record date or effective date for the event specified in such notice unless such
prior notice is waived by the Registered Holder in writing.

 

    	6

    	 

    

  

8.                 
No Rights of Shareholders. Subject to other Sections of this Warrant and the provisions of the Purchase Agreement
and the Certificate of Incorporation, the Registered Holder shall not be entitled to vote, to receive dividends or subscription
rights, nor shall anything contained herein be construed to confer upon the Registered Holder, as such, any of the rights of a
shareholder of the Company, including without limitation any right to vote for the election of directors or upon any matter submitted
to shareholders, to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification
of stock, change of par value or change of stock to no par value, consolidation, merger, conveyance, or otherwise), to receive
notices, or otherwise, until the Warrant shall have been exercised as provided herein.

 

9.                 
Replacement of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement
reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the Company
will issue, in lieu thereof, a new Warrant of like tenor.

 

10.             
Mailing of Notices, Etc. All notices, requests, consents, and other communications in connection with this
Warrant shall be in writing and shall be deemed delivered (i) three (3) business days after being sent by registered or certified
mail, return receipt requested, postage prepaid, (ii) one (1) business day after being sent via a reputable overnight courier
service guaranteeing next business day delivery in the Registered Holder’s country or region, or (iii) on actual receipt
if delivered by facsimile or by hand, in each case delivery shall be made to the intended recipient as set forth below:

 

If to the Company:

 

Frederick’s of Hollywood Group Inc.

6255 Sunset Blvd., 6th Floor

Hollywood, CA 90028

Facsimile No.: (323) 464−4219

Attention: Thomas J. Lynch, Chief Executive Officer

 

With a copy to:

 

Graubard Miller

405 Lexington Avenue

New York, New York 10174

Facsimile No.: (212) 818−8881

Attention: David Alan Miller, Esq.

 

If to the Registered Holder:

 

To the address set
forth in the Warrant Register as described in Section 4 hereof.

 

11.             
Change or Waiver. Any term of this Warrant may be changed or waived only by an instrument in writing signed
by the party against which enforcement of the change or waiver is sought.

 

    	7

    	 

    

  

12.             
Headings. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise
affect the meaning of any provision of this Warrant.

 

13.             
Severability. If any provision of this Warrant shall be held to be invalid and unenforceable, such invalidity
or unenforceability shall not affect any other provision of this Warrant.

 

14.             
Governing Law and Submission to Jurisdiction. This Warrant will be governed by and construed in accordance
with the laws of the State of New York without regard to principles of conflict or choice of laws of any jurisdiction (other than
§ 5-1401 of the New York General Obligations Law). The parties hereby agree that any action, proceeding or claim against
it arising out of, or relating in any way to this Warrant shall be brought and enforced in the courts of the State of New York,
and irrevocably submit to such jurisdiction, which jurisdiction shall be exclusive.

 

15.             
Supplements and Amendments. The Company and the Registered Holder may from time to time supplement or amend
this Warrant in order to cure any ambiguity, to correct or supplement any provision contained herein which may be defective or
inconsistent with any provision herein, or to make any other provisions in regard to matters or questions arising hereunder which
the Company and the Registered Holder may deem necessary or desirable.

 

16.             
Successors. All the covenants and provisions of this Warrant shall be binding upon and inure to the benefit
of the Company and the Registered Holder and their respective successors and assigns hereunder.

 

17.             
Benefits of this Warrant. Nothing in this Warrant shall be construed to give to any person, entity or corporation
other than the Company and the Registered Holder of the Warrant any legal or equitable right, remedy or claim under this Warrant;
and this Warrant shall be for the sole and exclusive benefit of the Company and the Registered Holder of the Warrant.

 

[SIGNATURE PAGE FOLLOWS]

 

    	8

    	 

    

   

IN WITNESS WHEREOF, FREDERICK’S
OF HOLLYWOOD GROUP INC. has caused this Warrant to be signed by its duly authorized officers under its corporate seal and to be
dated on the day and year first written above.

 

 

	 	FREDERICK’S OF HOLLYWOOD GROUP INC.
	 	 
	 	By: 	/s/ Thomas J. Lynch
	 	Name: 	Thomas J. Lynch
	 	Title: 	Chief Executive Officer
	 	 	

 

    	 

    	 

    

   

ANNEX A

 

NOTICE OF EXERCISE FORM

 

	To:	Dated:

 

In accordance with
the Warrant enclosed with this Form of Election to Purchase, the undersigned hereby irrevocably elects to purchase _____________
shares of common stock (“Common Stock”), $.01 par value per share, of Frederick’s of Hollywood
Group Inc. (“Company”) and encloses herewith $________ in cash, certified or official bank check or checks
or other immediately available funds, which sum represents the aggregate Exercise Price (as defined in the Warrant) for the number
of shares of Common Stock to which this Form of Election to Purchase relates, together with any applicable taxes payable by the
undersigned pursuant to the Warrant.

 

or

 

In accordance with
the Warrant enclosed with this Form of Election to Purchase, the undersigned hereby irrevocably elects to purchase ____________
shares of common stock (“Common Stock”), $.01 par value per share, of Frederick’s of Hollywood
Group Inc. (“Company”) by surrender of the unexercised portion of the attached Warrant (with a “Market
Value” of $____).

 

The undersigned hereby
represents, warrants to, and agrees with, the Company that:

 

(i) He/She/It is acquiring
the Warrant Shares for his/her/its own account and not with a view towards the distribution thereof;

 

(ii) He/She/It has
received a copy of all reports and documents required to be filed by the Company with the United States Securities and Exchange
Commission pursuant to the Securities Exchange Act of 1934, as amended, within the last 12 months and all reports issued by the
Company to its shareholders;

 

(iii) He/She/It understands
that he/she/it must bear the economic risk of the investment in the Warrant Shares, which cannot be sold unless they are registered
under the Securities Act of 1933 (the “Securities Act”) or an exemption therefrom is available thereunder
and that the Company is under no obligation to register the Warrant Shares for sale under the Securities Act;

 

(iv) He/She/It is aware
that the Company shall place stop transfer orders with its transfer agent against the transfer of the Warrant Shares in the absence
of registration under the Securities Act or an exemption therefrom as provided herein;

 

	Signature:  	 
	 	 
	Address:  	 

 

    	 

    	 

    

 

ANNEX B

 

ASSIGNMENT FORM

 

FOR VALUE RECEIVED,
_________________________________ hereby sells, assigns and transfers all of the rights of the undersigned under the attached Warrant
with respect to the number of shares of Common Stock covered thereby set forth below, unto:

 

	
        Name
of Assignee
	
        Address
	
        No.
of Shares

	 	 	 
	 	 	 
	 	 	 

 

	Dated:	 
	 	 
	Signature:	 
	 	 
	Dated:	 
	 	 
	Witness:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]